Global COVID-19 Drug Delivery Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global COVID-19 Drug Delivery Devices Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global COVID-19 drug delivery devices market has been segmented on the basis of product, route of administration, distribution channel, as well as regions and countries.
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body to safely achieve its desired therapeutic effect. COVID-19 drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Some devices are used as part of one or more medical treatments.
In light of the recent COVID-19 outbreak, economies across the globe have been, and continue to be, drastically impacted. There has been a significant surge in efforts by global industry players to expedite the development of a novel drug that is capable of treating this virus, due to the present lack of an adequate vaccine or treatment. This is a significant factor that is anticipated to exponentially boost the revenue growth of the global COVID-19 drug delivery devices market in the foreseeable future.
Increasing investments by private and government organizations to increase the availability of adequate countermeasures, as well as rising activities in the field of R&D for appropriate medical devices are other factors that are slated to have an impact of the market growth of this global industry in the years to come.
Segmentation of the global COVID-19 drug delivery devices market is as follows:
In terms of product, the prefilled syringe segment is slated to account for the majority revenue share of the global COVID-19 drug delivery devices market in 2021. This can be accredited to the numerous efforts being undertaken by respective governments to escalate the production and supply of prefilled syringes.
With respect to distribution channel, the hospital pharmacies segment is anticipated to account for the maximum number of revenue shares of this global market by 2021, as these devices for the successful delivery of drugs require medical assistance (available at these facilities) during the time of administration.
On the basis of route of administration, the parenteral segment is expected to account for the majority revenue share of this global market by 2021, and is slated to continue to do so for the next decade. This can be attributed to the fact that presently there isn’t a vaccine. In the event that a vaccine is found, biologics that are presently being explored such as, RNA and DNA-based vaccines, monoclonal antibodies, etc. can only be administered intravenously as their efficiency to perform degrades when taken orally or through the alimentary canal.
Regional Segmentation and Analysis:
North America is expected to account for the majority revenue share of the global COVID-19 drug delivery devices market by 2021, and to continue to do so in the coming years. This can be attributed to the large presence of key industry players in this region, a well-established healthcare infrastructure, and higher disposable incomes that allow individuals here the option to from advanced options for effective treatment.
The markets in the APAC region are also expected to register considerable growth during the forecast period, owing to the large prevalence of COVID-19 cases, increase in funding for R&D activities, as well as the immense populations currently present in this region.
Segmentation of the Global COVID-19 Drug Delivery Devices Market:
Segmentation by Product:
- Prefilled Syringe
- Needle-free Injectors
Segmentation by Route of Administration:
Segmentation by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2019 Estimated Year 2020 Forecast Period 2020–2029 Revenue in US$
- Johnson & Johnson Services Inc.
- Serum Institute of India Pvt. Ltd.
- GlaxoSmithKline Plc
- Moderna Inc.
- Bharat Biotech
- Pfizer Inc.
- PharmaJet Inc.
- Novavax Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!